POLYGLUTAMYLATION, AN IMPORTANT ELEMENT IN METHOTREXATE CYTO-TOXICITY AND SELECTIVITY IN TUMOR VERSUS MURINE GRANULOCYTIC PROGENITOR CELLS-INVITRO
- 1 January 1984
- journal article
- research article
- Vol. 44 (8) , 3190-3195
Abstract
Methotrexate (MTX) cytotoxicity was assessed by clonogenic assay in agar with granulocytic progenitor cells from mouse bone marrow and in the [mouse] Ehrlich ascites tumor, the K562 human chronic myelogenous leukemia and the P388 murine leukemia. After a 2-h exposure to MTX, the concentrations necessary to produce 50% inhibition of colony formation were 100, 25, 1.2 and 0.25 .mu.M, respectively. This was inversely related to the ability of the tumor cells to accumulate MTX polyglutamyl derivatives and consistent with the observation that no polyglutamyl derivatives were observed in granulocytic progenitor cells after a 2-h exposure to 5 .mu.m MTX. Continuous exposure to glycine (200 .mu.M)-adenosine (100 .mu.M)-thymidine (10 .mu.M) (GAT), along with MTX, protected cells from MTX cytotoxicity by circumventing the requirement for tetrahydrofolate cofactors. While the presence of GAT during a 2-h exposure to 5 .mu.M MTX is sufficient to protect granulocyte progenitor cells from MTX cytotoxicity, the presence of GAT, even after MTX is removed, is required to protect tumor cells. Indeed, if, after a 2-h exposure of tumor cells to MTX and GAT, both MTX and GAT are removed before plating in agar, cytotoxicity to tumor cells was expressed. This sustained antitumor effect of MTX correlates with the rapid build-up of polyglutamyl derivatives that are retained in the cell even after extracellular and intracellular monoglutamate is eliminated. This is in contrast to granulocytic progenitor cells which appear to be susceptible to the drug only during the period of exposure to the monoglutamate under these conditions. The marked differences in the accumulation of MTX polyglutamyl derivatives between the tumor cells studied and the murine bone marrow granulocytic progenitor cells are an important element in MTX selectivity.This publication has 21 references indexed in Scilit:
- EVIDENCE FOR THE CYTO-TOXIC ACTIVITY OF POLYGLUTAMATE DERIVATIVES OF METHOTREXATE1980
- Synthesis of Methotrexate Polyglutamates by Bone Marrow Cells from Patients with Leukemia and LymphomaDevelopmental Pharmacology and Therapeutics, 1980
- Rapid separation of low molecular weight solutes from liposomes without dilutionAnalytical Biochemistry, 1978
- In-Vitro Cloning Techniques for Hemopoietic Cells: Clinical ApplicationsAnnals of Internal Medicine, 1977
- Some Observations on the Reversibility of Methotrexate Toxicity in Normal Proliferating Tissues2JNCI Journal of the National Cancer Institute, 1977
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- MECHANISM OF ACTION OF METHOTREXATE .4. FREE INTRACELLULAR METHOTREXATE REQUIRED TO SUPPRESS DIHYDROFOLATE REDUCTION TO TETRAHYDROFOLATE BY EHRLICH ASCITES TUMOR-CELLS INVITRO1976
- REVERSAL OF METHOTREXATE CYTOTOXICITY TO MOUSE BONE-MARROW CELLS BY LEUCOVORIN AND NUCLEOSIDES1976
- TUMOR AND MARROW DAMAGE OCCURRING FROM METHOTREXATE, MONOFLUOROMETHOTREXATE, DIFLUOROMETHOTREXATE, AND DICHLOROMETHOTREXATE1961
- The Ability of Purine and Thymine Derivatives and of Glycine to Support the Growth of Mammalian Cells in CultureJournal of Biological Chemistry, 1959